|
|
MicroRNAs and their roles in osteoclast differentiation |
Zhuying Xia, Chao Chen, Peng Chen, Hui Xie, Xianghang Luo() |
Institute of Endocrinology and Metabolism, the Second Xiangya Hospital of Central South University, Changsha 410011, China |
|
|
Abstract Osteoclasts, which are derived from monocyte-macrophage precursors, are exclusive bone resorption cells. Limited evidence indicates that a class of small non-coding single-stranded RNAs known as “microRNAs” (miRNAs) is also involved in bone resorption. Although various miRNAs regulate cell proliferation and differentiation, few miRNAs have been reported to play a key role in the regulation of osteoclast differentiation. In this short review, the biology and functional mechanisms of miRNAs in osteoclastogenesis are summarized. The profiling, function, and target prediction of miRNAs are discussed as well.
|
Keywords
miRNA
osteoclast differentiation
antagomirs
|
Corresponding Author(s):
Luo Xianghang,Email:xianghangluo@yahoo.cn
|
Issue Date: 05 December 2011
|
|
1 |
Suda T, Udagawa N, Nakamura I, Miyaura C, Takahashi N. Modulation of osteoclast differentiation by local factors. Bone 1995; 17(2 Suppl 1): S87–S91 doi: 10.1016/8756-3282(95)00185-G pmid:8579904
|
2 |
Karsenty G, Wagner EF. Reaching a genetic and molecular understanding of skeletal development. Dev Cell 2002; 2(4): 389–406 doi: 10.1016/S1534-5807(02)00157-0 pmid:11970890
|
3 |
Tanaka S, Nakamura K, Takahasi N, Suda T. Role of RANKL in physiological and pathological bone resorption and therapeutics targeting the RANKL-RANK signaling system. Immunol Rev 2005; 208(1): 30–49 doi: 10.1111/j.0105-2896.2005.00327.x pmid:16313339
|
4 |
Soriano P, Montgomery C, Geske R, Bradley A. Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice. Cell 1991; 64(4): 693–702 doi: 10.1016/0092-8674(91)90499-O pmid:1997203
|
5 |
Grigoriadis AE, Wang ZQ, Cecchini MG, Hofstetter W, Felix R, Fleisch HA, Wagner EF. c-Fos: a key regulator of osteoclast-macrophage lineage determination and bone remodeling. Science 1994; 266(5184): 443–448 doi: 7939685" target="_blank">10.1126/science. pmid:7939685 pmid:7939685
|
6 |
Tondravi MM, McKercher SR, Anderson K, Erdmann JM, Quiroz M, Maki R, Teitelbaum SL. Osteopetrosis in mice lacking haematopoietic transcription factor PU.1. Nature 1997; 386(6620): 81–84 doi: 10.1038/386081a0 pmid:9052784
|
7 |
Iotsova V, Caama?o J, Loy J, Yang Y, Lewin A, Bravo R. Osteopetrosis in mice lacking NF-κB1 and NF-κB2. Nat Med 1997; 3(11): 1285–1289 doi: 10.1038/nm1197-1285 pmid:9359707
|
8 |
Takayanagi H, Kim S, Koga T, Nishina H, Isshiki M, Yoshida H, Saiura A, Isobe M, Yokochi T, Inoue J, Wagner EF, Mak TW, Kodama T, Taniguchi T. Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev Cell 2002; 3(6): 889–901 doi: 10.1016/S1534-5807(02)00369-6 pmid:12479813
|
9 |
Kim VN. MicroRNA biogenesis: coordinated cropping and dicing. Nat Rev Mol Cell Biol 2005; 6(5): 376–385 doi: 10.1038/nrm1644 pmid:15852042
|
10 |
Mizuno Y, Yagi K, Tokuzawa Y, Kanesaki-Yatsuka Y, Suda T, Katagiri T, Fukuda T, Maruyama M, Okuda A, Amemiya T, Kondoh Y, Tashiro H, Okazaki Y. miR-125b inhibits osteoblastic differentiation by down-regulation of cell proliferation. Biochem Biophys Res Commun 2008; 368(2): 267–272 doi: 10.1016/j.bbrc.2008.01.073 pmid:18230348
|
11 |
Luzi E, Marini F, Sala SC, Tognarini I, Galli G, Brandi ML. Osteogenic differentiation of human adipose tissue-derived stem cells is modulated by the miR-26a targeting of the SMAD1 transcription factor. J Bone Miner Res 2008; 23(2): 287–295 doi: 10.1359/jbmr.071011 pmid:18197755
|
12 |
Li ZY, Hassan MQ, Volinia S, van Wijnen AJ, Stein JL, Croce CM, Lian JB, Stein GS. A microRNA signature for a BMP2-induced osteoblast lineage commitment program. Proc Natl Acad Sci USA 2008; 105(37): 13906–13911 doi: 10.1073/pnas.0804438105 pmid:18784367
|
13 |
Huang J, Zhao L, Xing L, Chen D. MicroRNA-204 regulates Runx2 protein expression and mesenchymal progenitor cell differentiation. Stem Cells 2010; 28(2): 357–364 pmid:20039258
|
14 |
Kapinas K, Kessler CB, Delany AM. miR-29 suppression of osteonectin in osteoblasts: regulation during differentiation and by canonical Wnt signaling. J Cell Biochem 2009; 108(1): 216–224 doi: 10.1002/jcb.22243 pmid:19565563
|
15 |
Itoh T, Nozawa Y, Akao Y. MicroRNA-141 and -200a are involved in bone morphogenetic protein-2-induced mouse pre-osteoblast differentiation by targeting distal-less homeobox 5. J Biol Chem 2009; 284(29): 19272–19279 doi: 10.1074/jbc.M109.014001 pmid:19454767
|
16 |
Inose H, Ochi H, Kimura A, Fujita K, Xu R, Sato S, Iwasaki M, Sunamura S, Takeuchi Y, Fukumoto S, Saito K, Nakamura T, Siomi H, Ito H, Arai Y, Shinomiya K, Takeda S. A microRNA regulatory mechanism of osteoblast differentiation. Proc Natl Acad Sci USA 2009; 106(49): 20794–20799 doi: 10.1073/pnas.0909311106 pmid:19933329
|
17 |
Li ZY, Hassan MQ, Jafferji M, Aqeilan RI, Garzon R, Croce CM, van Wijnen AJ, Stein JL, Stein GS, Lian JB. Biological functions of miR-29b contribute to positive regulation of osteoblast differentiation. J Biol Chem 2009; 284(23): 15676–15684 doi: 10.1074/jbc.M809787200 pmid:19342382
|
18 |
Mizuno Y, Tokuzawa Y, Ninomiya Y, Yagi K, Yatsuka-Kanesaki Y, Suda T, Fukuda T, Katagiri T, Kondoh Y, Amemiya T, Tashiro H, Okazaki Y. miR-210 promotes osteoblastic differentiation through inhibition of AcvR1b. FEBS Lett 2009; 583(13): 2263–2268 doi: 10.1016/j.febslet.2009.06.006 pmid:19520079
|
19 |
Kim YJ, Bae SW, Yu SS, Bae YC, Jung JS. miR-196a regulates proliferation and osteogenic differentiation in mesenchymal stem cells derived from human adipose tissue. J Bone Miner Res 2009; 24(5): 816–825 doi: 10.1359/jbmr.081230 pmid:19063684
|
20 |
Li H, Xie H, Liu W, Hu R, Huang B, Tan YF, Xu K, Sheng ZF, Zhou HD, Wu XP, Luo XH. A novel microRNA targeting HDAC5 regulates osteoblast differentiation in mice and contributes to primary osteoporosis in humans. J Clin Invest 2009; 119(12): 3666–3677 doi: 10.1172/JCI39832 pmid:19920351
|
21 |
Xu XH, Dong SS, Guo Y, Yang TL, Lei SF, Papasian CJ, Zhao M, Deng HW. Molecular genetic studies of gene identification for osteoporosis: the 2009 update. Endocr Rev 2010; 31(4): 447–505 doi: 10.1210/er.2009-0032 pmid:20357209
|
22 |
Ambros V, Chen X. The regulation of genes and genomes by small RNAs. Development 2007; 134(9): 1635–1641 doi: 10.1242/dev.002006 pmid:17409118
|
23 |
Cullen BR. Transcription and processing of human microRNA precursors. Mol Cell 2004; 16(6): 861–865 doi: 10.1016/j.molcel.2004.12.002 pmid:15610730
|
24 |
Bentwich I, Avniel A, Karov Y, Aharonov R, Gilad S, Barad O, Barzilai A, Einat P, Einav U, Meiri E, Sharon E, Spector Y, Bentwich Z. Identification of hundreds of conserved and nonconserved human microRNAs. Nat Genet 2005; 37(7): 766–770 doi: 10.1038/ng1590 pmid:15965474
|
25 |
Lagos-Quintana M, Rauhut R, Lendeckel W, Tuschl T. Identification of novel genes coding for small expressed RNAs. Science 2001; 294(5543): 853–858 doi: 10.1126/science.1064921 pmid:11679670
|
26 |
Lee Y, Jeon K, Lee JT, Kim S, Kim VN. MicroRNA maturation: stepwise processing and subcellular localization. EMBO J 2002; 21(17): 4663–4670 doi: 10.1093/emboj/cdf476 pmid:12198168
|
27 |
Rodriguez A, Griffiths-Jones S, Ashurst JL, Bradley A. Identification of mammalian microRNA host genes and transcription units. Genome Res 2004; 14( 10A): 1902–1910 doi: 10.1101/gr.2722704 pmid:15364901
|
28 |
Carthew RW, Sontheimer EJ. Origins and mechanisms of miRNAs and siRNAs. Cell 2009; 136(4): 642–655 doi: 10.1016/j.cell.2009.01.035 pmid:19239886
|
29 |
Bushati N, Cohen SM. microRNA functions. Annu Rev Cell Dev Biol 2007; 23(1): 175–205 doi: 10.1146/annurev.cellbio.23.090506.123406 pmid:17506695
|
30 |
Gregory RI, Yan KP, Amuthan G, Chendrimada T, Doratotaj B, Cooch N, Shiekhattar R. The microprocessor complex mediates the genesis of microRNAs. Nature 2004; 432(7014): 235–240 doi: 10.1038/nature03120 pmid:15531877
|
31 |
Tan GS, Garchow BG, Liu X, Yeung J, Morris JP 4th, Cuellar TL, McManus MT, Kiriakidou M. Expanded RNA-binding activities of mammalian Argonaute 2. Nucleic Acids Res 2009; 37(22): 7533–7545 doi: 10.1093/nar/gkp812 pmid:19808937
|
32 |
Pillai RS, Bhattacharyya SN, Filipowicz W. Repression of protein synthesis by miRNAs: how many mechanisms? Trends Cell Biol 2007; 17(3): 118–126 doi: 10.1016/j.tcb.2006.12.007 pmid:17197185
|
33 |
Zeng Y, Yi R, Cullen BR. MicroRNAs and small interfering RNAs can inhibit mRNA expression by similar mechanisms. Proc Natl Acad Sci USA 2003; 100(17): 9779–9784 doi: 10.1073/pnas.1630797100 pmid:12902540
|
34 |
Yekta S, Shih IH, Bartel DP. MicroRNA-directed cleavage of HOXB8 mRNA. Science 2004; 304(5670): 594–596 doi: 10.1126/science.1097434 pmid:15105502
|
35 |
Krützfeldt J, Poy MN, Stoffel M. Strategies to determine the biological function of microRNAs. Nat Genet 2006; 38(Suppl): S14–S19 doi: 10.1038/ng1799 pmid:16736018
|
36 |
Castoldi M, Schmidt S, Benes V, Noerholm M, Kulozik AE, Hentze MW, Muckenthaler MU. A sensitive array for microRNA expression profiling (miChip) based on locked nucleic acids (LNA). RNA 2006; 12(5): 913–920 doi: 10.1261/rna.2332406 pmid:16540696
|
37 |
Kauppinen S, Vester B, Wengel J. Locked nucleic acid: high-affinity targeting of complementary RNA for RNomics. Handb Exp Pharmacol 2006; (173): 405–422
|
38 |
Auer H, Newsom DL, Kornacker K. Expression profiling using Affymetrix GeneChip microarrays. Methods Mol Biol 2009; 509: 35–46 doi: 10.1007/978-1-59745-372-1_3 pmid:19212713
|
39 |
Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA, Downing JR, Jacks T, Horvitz HR, Golub TR. MicroRNA expression profiles classify human cancers. Nature 2005; 435(7043): 834–838 doi: 10.1038/nature03702 pmid:15944708
|
40 |
Schmittgen TD, Lee EJ, Jiang J, Sarkar A, Yang L, Elton TS, Chen C. Real-time PCR quantification of precursor and mature microRNA. Methods 2008; 44(1): 31–38 doi: 10.1016/j.ymeth.2007.09.006 pmid:18158130
|
41 |
Chen C, Ridzon DA, Broomer AJ, Zhou Z, Lee DH, Nguyen JT, Barbisin M, Xu NL, Mahuvakar VR, Andersen MR, Lao KQ, Livak KJ, Guegler KJ. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res 2005; 33(20): e179 doi: 10.1093/nar/gni178 pmid:16314309
|
42 |
Sugatani T, Vacher J, Hruska KA. A microRNA expression signature of osteoclastogenesis. Blood 2011; 117(13): 3648–3657 doi: 10.1182/blood-2010-10-311415 pmid:21273303
|
43 |
Marzia M, Sims NA, Voit S, Migliaccio S, Taranta A, Bernardini S, Faraggiana T, Yoneda T, Mundy GR, Boyce BF, Baron R, Teti A. Decreased c-Src expression enhances osteoblast differentiation and bone formation. J Cell Biol 2000; 151(2): 311–320 doi: 10.1083/jcb.151.2.311 pmid:11038178
|
44 |
Del Fattore A, Teti A, Rucci N. Osteoclast receptors and signaling. Arch Biochem Biophys 2008; 473(2): 147–160 doi: 10.1016/j.abb.2008.01.011 pmid:18237538
|
45 |
Franzoso G, Carlson L, Xing L, Poljak L, Shores EW, Brown KD, Leonardi A, Tran T, Boyce BF, Siebenlist U. Requirement for NF-κB in osteoclast and B-cell development. Genes Dev 1997; 11(24): 3482–3496 doi: 10.1101/gad.11.24.3482 pmid:9407039
|
46 |
Ishida N, Hayashi K, Hoshijima M, Ogawa T, Koga S, Miyatake Y, Kumegawa M, Kimura T, Takeya T. Large scale gene expression analysis of osteoclastogenesis in vitro and elucidation of NFAT2 as a key regulator. J Biol Chem 2002; 277(43): 41147–41156 doi: 10.1074/jbc.M205063200 pmid:12171919
|
48 |
Takayanagi H, Kim S, Matsuo K, Suzuki H, Suzuki T, Sato K, Yokochi T, Oda H, Nakamura K, Ida N, Wagner EF, Taniguchi T. RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-beta. Nature 2002; 416(6882): 744–749 doi: 10.1038/416744a pmid:11961557
|
49 |
Weilbaecher KN, Motyckova G, Huber WE, Takemoto CM, Hemesath TJ, Xu Y, Hershey CL, Dowland NR, Wells AG, Fisher DE. Linkage of M-CSF signaling to Mitf, TFE3, and the osteoclast defect in Mitf(mi/mi) mice. Mol Cell 2001; 8(4): 749–758 doi: 10.1016/S1097-2765(01)00360-4 pmid:11684011
|
50 |
Sugatani T, Hruska KA. Impaired micro-RNA pathways diminish osteoclast differentiation and function. J Biol Chem 2009; 284(7): 4667–4678 doi: 10.1074/jbc.M805777200 pmid:19059913
|
51 |
Keen R. Osteoporosis: strategies for prevention and management. Best Pract Res Clin Rheumatol 2007; 21(1): 109–122 doi: 10.1016/j.berh.2006.10.004 pmid:17350547
|
52 |
Lakshmipathy U, Hart RP. Concise review: microRNA expression in multipotent mesenchymal stromal cells. Stem Cells 2008; 26(2): 356–363 doi: 10.1634/stemcells.2007-0625 pmid:17991914
|
53 |
Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell 2009; 136(2): 215–233 doi: 10.1016/j.cell.2009.01.002 pmid:19167326
|
54 |
Yue D, Liu H, Huang Y. Survey of computational algorithms for microRNA target prediction. Curr Genomics 2009; 10(7): 478–492 doi: 10.2174/138920209789208219 pmid:20436875
|
55 |
Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005; 120(1): 15–20 doi: 10.1016/j.cell.2004.12.035 pmid:15652477
|
56 |
Krek A, Grün D, Poy MN, Wolf R, Rosenberg L, Epstein EJ, MacMenamin P, da Piedade I, Gunsalus KC, Stoffel M, Rajewsky N. Combinatorial microRNA target predictions. Nat Genet 2005; 37(5): 495–500 doi: 10.1038/ng1536 pmid:15806104
|
57 |
John B, Enright AJ, Aravin A, Tuschl T, Sander C, Marks DS. Human microRNA targets. PLoS Biol 2004; 2(11): e363 doi: 10.1371/journal.pbio.0020363 pmid:15502875
|
58 |
Griffiths-Jones S, Grocock RJ, van Dongen S, Bateman A, Enright AJ. miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res 2006; 34(Suppl 1): D140–D144 doi: 10.1093/nar/gkj112 pmid:16381832
|
59 |
Hsu PW, Huang HD, Hsu SD, Lin LZ, Tsou AP, Tseng CP, Stadler PF, Washietl S, Hofacker IL. miRNAMap: genomic maps of microRNA genes and their target genes in mammalian genomes. Nucleic Acids Res 2006; 34(Suppl 1): D135–D139 doi: 10.1093/nar/gkj135 pmid:16381831
|
60 |
Megraw M, Sethupathy P, Corda B, Hatzigeorgiou AG. miRGen: a database for the study of animal microRNA genomic organization and function. Nucleic Acids Res 2007; 35(Suppl 1): D149–D155 doi: 10.1093/nar/gkl904 pmid:17108354
|
61 |
Meister G, Landthaler M, Dorsett Y, Tuschl T. Sequence-specific inhibition of microRNA- and siRNA-induced RNA silencing. RNA 2004; 10(3): 544–550 doi: 10.1261/rna.5235104 pmid:14970398
|
62 |
Krützfeldt J, Rajewsky N, Braich R, Rajeev KG, Tuschl T, Manoharan M, Stoffel M. Silencing of microRNAs in vivo with ‘antagomirs’. Nature 2005; 438(7068): 685–689 doi: 10.1038/nature04303 pmid:16258535
|
63 |
Krützfeldt J, Kuwajima S, Braich R, Rajeev KG, Pena J, Tuschl T, Manoharan M, Stoffel M. Specificity, duplex degradation and subcellular localization of antagomirs. Nucleic Acids Res 2007; 35: 2885–2892 doi: 10.1093/nar/gkm024 pmid:17439965
|
64 |
Horwich MD, Zamore PD. Design and delivery of antisense oligonucleotides to block microRNA function in cultured Drosophila and human cells. Nat Protoc 2008; 3(10): 1537–1549 doi: 10.1038/nprot.2008.145 pmid:18802435
|
65 |
Nasevicius A, Ekker SC. Effective targeted gene ‘knockdown’ in zebrafish. Nat Genet 2000; 26(2): 216–220 doi: 10.1038/79951 pmid:11017081
|
66 |
Zellweger T, Miyake H, Cooper S, Chi K, Conklin BS, Monia BP, Gleave ME. Antitumor activity of antisense clusterin oligonucleotides is improved in vitro and in vivo by incorporation of 2′-O-(2-methoxy)ethyl chemistry. J Pharmacol Exp Ther 2001; 298(3): 934–940 pmid:11504787
|
67 |
Dean NM, Bennett CF. Antisense oligonucleotide-based therapeutics for cancer. Oncogene 2003; 22(56): 9087–9096 doi: 10.1038/sj.onc.1207231 pmid:14663487
|
68 |
Kastelein JJ, Wedel MK, Baker BF, Su J, Bradley JD, Yu RZ, Chuang E, Graham MJ, Crooke RM. Potent reduction of apolipoprotein B and low-density lipoprotein cholesterol by short-term administration of an antisense inhibitor of apolipoprotein B. Circulation 2006; 114(16): 1729–1735 doi: 10.1161/CIRCULATIONAHA.105.606442 pmid:17030687
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|